Skip to main content
Figure 1 | BMC Musculoskeletal Disorders

Figure 1

From: Lipopolysaccharide treatment suppresses spontaneously developing ankylosing enthesopathy in B10.BR male mice: The potential role of interleukin-10

Figure 1

ANKENT occurrence and LPS administrations. LPS or PBS was administered i.p. to B10.BR males from the age of 3–3.5 months in two-weeks intervals (four times). The ANKENT occurrence was recorded throughout the whole experiment. The incidence of ANKENT was significantly lower in the LPS-treated group (1/55) compared to control PBS group (10/70; Fisher’s exact test p < 0.02). To analyze immune parameters sera and spleens were collected three days after the second and the fourth LPS dose and at the end of experiment (3x9 mice of each group).

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us